Amanda Hamilton | IR Officer |
Christopher Martin | Co-Founder, CEO & Director |
Jennifer Herron | Chief Commercial Officer & SVP |
Jay Feingold | Chief Medical Officer, Head, Oncology Clinical Development & SVP |
Jennifer Creel | CFO |
Zhen Zeng | Morgan Stanley |
Tazeen Ahmad | Bank of America Merrill Lynch |
Good morning, and welcome to the ADC Therapeutics First Quarter Results 2021 Financial Call. My name is Cheryl, and I will be your operator for today's call. [Operator Instructions]. I will now turn the call over to Amanda Hamilton, you may begin.
Thank you, operator.